DNMT1 and neoplasm: An article already referred to [20] has shown that decitabine, an inhibitor of DNA methyltransferase 1 (DNMT1) induced, as expected, DNA hypomethylation, which led to increased PD-L1 expression as well as increased expression of immune-related genes and tumor infiltration of T cells [20].